LogicBio Therapeutics, Inc.·4

Aug 29, 4:15 PM ET

Wilton Thomas 4

4 · LogicBio Therapeutics, Inc. · Filed Aug 29, 2019

Insider Transaction Report

Form 4
Period: 2019-08-27
Wilton Thomas
Chief Business Officer
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-08-27+75,000139,108 total
    Exercise: $0.73Exp: 2027-11-02Common Stock (75,000 underlying)
  • Exercise/Conversion

    Common Stock

    2019-08-27$0.73/sh+75,000$54,75075,000 total
Footnotes (1)
  • [F1]The option vested 25% on the first anniversary of the vesting commencement date, September 6, 2017, and in equal one thirty-sixth monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION